260
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Risk of cardiovascular disease is driven by different combinations of environmental, medical and behavioral factors: Building a conceptual model for cumulative risk assessment

, &
Pages 1902-1925 | Received 03 Mar 2021, Accepted 29 Apr 2021, Published online: 26 May 2021

References

  • Alcendor DJ. 2020. Racial disparities-associated COVID-19 mortality among minority populations in the US. J Clin Med. 9(8):2442. doi:10.3390/jcm9082442
  • Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, et al. 2010. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 29(3):730–741. doi:10.1002/etc.34
  • Araujo J. 2012. Expert consultation.
  • Barraj LM, Tran NL, Goodman M, Ginevan ME. 2008. Perspective: Risk apportionment and disease intervention strategies. Risk Anal. 28(2):477–486. doi:10.1111/j.1539-6924.2008.01028.x
  • Barrett-Connor EL. 1985. Obesity, atherosclerosis, and coronary artery disease. Ann Intern Med. 103(6_Part_2):1010. doi:10.7326/0003-4819-103-6-1010
  • Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP, Lloyd-Jones DM. 2012. Lifetime risks of cardiovascular disease. N Engl J Med. 366(4):321–329. doi:10.1056/NEJMoa1012848
  • Black PH. 2006. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses. 67(4):879–891. doi:10.1016/j.mehy.2006.04.008
  • Bøggild H, Knutsson A. 1999. Shift work, risk factors and cardiovascular disease. Scand J Work Environ Health. 25(2):85–99. doi:10.5271/sjweh.410
  • Brewer LE, Wright JM, Rice G, Neas L, Teuschler L. 2017. Causal inference in cumulative risk assessment: the roles of directed acyclic graphs. Environ Int. 102:30–41. doi:10.1016/j.envint.2016.12.005
  • Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC, et al. 2004. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 109(21):2655–2671. doi:10.1161/01.CIR.0000128587.30041.C8
  • Carney RM, Freedland KE, Veith RC. 2005. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med. 67:S29–S33.
  • CDC. 2020. National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, Center for Disease Control, U.S. Department of Health & Human Services. https://www.cdc.gov/heartdisease/facts.htm. Page last reviewed: September 8, 2020
  • Clark AM, DesMeules M, Luo W, Duncan AS, Wielgosz A. 2009. Socioeconomic status and cardiovascular disease: risks and implications for care. Nat Rev Cardiol. 6(11):712–722. doi:10.1038/nrcardio.2009.163
  • Cormier SA, Suter II GW. 2008. A framework for fully integrating environmental assessment. Environ Manage. 42:543–556.
  • D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. 2008. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579
  • Dansereau DF, Simpson DD. 2009. A picture is worth a thousand words: The case for graphic representations. Prof Psychol Res Pr. 40(1):104–110. doi:10.1037/a0011827
  • Dawber TR, Meadors GF, Moore FE. 1951. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 41(3):279–286. doi:10.2105/AJPH.41.3.279
  • Dennison WC, Lookingbill TR, Carruthers TJB, Hawkey JM, Carter SL. 2007. An eye‐opening approach to developing and communicating integrated environmental assessments. Front Ecol Environ. 5(6):307–314. doi:10.1890/1540-9295(2007)5[307:AEATDA2.0.CO;2]
  • Dimsdale JE. 2008. Psychological stress and cardiovascular disease. J Am Coll Cardiol. 51(13):1237–1246. doi:10.1016/j.jacc.2007.12.024
  • El-Khatib Z, Jacobs GB, Ikomey GM, Neogi U. 2020. The disproportionate effect of COVID-19 mortality on ethnic minorities: Genetics or health inequalities? EClinicalMedicine. 23:100430. doi:10.1016/j.eclinm.2020.100430
  • Esch T, Stefano GB, Fricchione GL, Benson H. 2002. Stress in cardiovascular diseases. Med Sci Monit. 8(5):RA93–RA101.
  • Fox MA, Brewer LE, Martin L. 2017. An overview of literature topics related to current concepts, methods, tools, and applications for cumulative risk assessment (2007–2016). Int J Environ Res Public Health. 14(4):389. doi:10.3390/ijerph14040389
  • Fox MA, Spicer K, Chosewood LC, Susi P, Johns DO, Dotson GS. 2018. Implications of applying cumulative risk assessment to the workplace. Environ Int. 115:230–238. doi:10.1016/j.envint.2018.03.026
  • Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y. 1999. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med. 38(2):202–206. doi:10.2169/internalmedicine.38.202
  • Guldiken S, Demir M, Arikan E, Turgut B, Azcan S, Gerenli M, Tugrul A. 2007. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: soluble CD40 ligand and high-sensitivity C-reactive protein. Thromb Res. 119(1):79–84. doi:10.1016/j.thromres.2005.12.019
  • Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC, Hofman A, Witteman JC. 1999. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 19(8):1986–1991. doi:10.1161/01.ATV.19.8.1986
  • Holling CS, editor. 1978. Adaptive environmental assessment and management. International Series on Applied Systems Analysis; vol. 3. Toronto: John Wiley & Sons, International Institute for Applied Systems Analysis.
  • Howard RA, Matheson JE. 2005. Influence diagrams. Decis Anal. 2(3):127–143. " doi:10.1287/deca.1050.0020
  • Hubert HB, Feinleib M, McNamara PM, Castelli WP. 1983. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 67(5):968–977. doi:10.1161/01.CIR.67.5.968
  • Kannel WB, Sorlie P. 1979. Some health benefits of physical activity: the Framingham Study. Arch Intern Med. 139(8):857–861. doi:10.1001/archinte.1979.03630450011006
  • Kris-Etherton PM, Harris WS, Appel LJ. 2003. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 23(2):e20–e30.
  • Le N. 2006. Hyperlipidemia and cardiovascular disease. Curr Opin Lipidol. 17(6):702–704. doi:10.1097/MOL.0b013e328010a05b
  • Lentz TJ, Dotson GS, Williams PR, Maier A, Gadagbui B, Pandalai SP, Lamba A, Hearl F, Mumtaz M. 2015. Aggregate exposure and cumulative risk assessment—integrating occupational and non-occupational risk factors. J Occup Environ Hyg. 12(sup1):S112–S126. doi:10.1080/15459624.2015.1060326
  • Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, et al. 2006. Diet and lifestyle recommendations revision 2006 A scientific statement from the American Heart Association nutrition committee. Circulation. 114(1):82–96. doi:10.1161/CIRCULATIONAHA.106.176158
  • Lusis AJ. 2003. Genetic factors in cardiovascular disease: 10 questions. Trends Cardiovasc Med. 13(8):309–316. doi:10.1016/j.tcm.2003.08.001
  • Marmot M, Brunner E. 1991. Alcohol and cardiovascular disease: the status of the U shaped curve. Br Med J. 303(6802):565–568. doi:10.1136/bmj.303.6802.565
  • McGill Jr. HC, McMahan CA, Herderick EE, Zieske AW, Malcom GT, Tracy RE, Strong JP. 2002. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 105(23):2712–2718. doi:10.1161/01.CIR.0000018121.67607.CE
  • Menzie CA, MacDonell MM, Mumtaz M. 2007. A phased approach for assessing combined effects from multiple stressors. Environ Health Perspect. 115(5):807–816. doi:10.1289/ehp.9331
  • Messner B, Bernhard D. 2010. Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance. Biometals. 23(5):811–822. doi:10.1007/s10534-010-9314-4
  • Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. 2002. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol. 90(12):1279–1283. doi:10.1016/S0002-9149(02)02863-1
  • Monarca S, Donato F, Zerbini I, Calderon RL, Craun GF. 2006. Review of epidemiological studies on drinking water hardness and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil. 13(4):495–506. doi:10.1097/01.hjr.0000214608.99113.5c
  • Moretto A, Bachman A, Boobis A, Solomon KR, Pastoor TP, Wilks M, Embry M. 2017. A framework for cumulative risk assessment in the 21st century. Crit Rev Toxicol. 47(2):85–97. doi:10.1080/10408444.2016.1211618
  • Morland K, Diez Roux AV, Wing S. 2006. Supermarkets, other food stores, and obesity: the atherosclerosis risk in communities study. Am J Pre Med. 30(4):333–339. doi:10.1016/j.amepre.2005.11.003
  • Nabe-Nielsen K, Quist HG, Garde AH, Aust B. 2011. Shiftwork and changes in health behaviors. J Occup Environ Med. 53(12):1413–1417. doi:10.1097/JOM.0b013e31823401f0
  • National Research Council (NRC). 1986. Ecological knowledge and environmental problem-solving: concepts and case studies. Washington (DC): The National Academies Press. doi:10.17226/645
  • National Research Council (NRC). 2009. Science and decisions: advancing risk assessment. Washington, DC: The National Academies Press. doi:10.17226/12209
  • Neal B. 2012. Expert consultation.
  • Niemeier RT, Williams PRD, Rossner A, Clougherty J, Rice G. 2020. A cumulative risk perspective for occupational health and safety (OHS) professionals. Int J Environ Res Public Health. 17:1–19.
  • Norton SB, Schofield KA. 2017. Conceptual model diagrams as evidence scaffolds for environmental assessment and management. Freshw Sci. 36(1):231–239. doi:10.1086/690296
  • Office of Environmental Health Hazard Assessment (OEHHA). 2018. CalEnviroScreen Version 3.0: The California Communities Environmental Health Screening Tool. California Environmental Protection Agency. https://oehha.ca.gov/calenviroscreen/report/calenviroscreen-30. Tool available at: https://oehha.ca.gov/calenviroscreen.
  • Reid WV, Mooney HA, Cropper A, Capistrano D, Carpenter SR, Chopra K, Dasgupta P, Dietz T, Duraiappah AK, Hassan R, et al. 2005. Ecosystems and human well-being: synthesis. Millennium Ecosystem Assessment. Washington (DC): Island Press. http://www.maweb.org/documents/document.356.aspx.pdf.
  • Richardson CR, Kriska AM, Lantz PM, Hayward RA. 2004. Physical activity and mortality across cardiovascular disease risk groups. Med Sci Sports Exerc. 36(11):1923–1929.
  • Rich-Edwards JW, Stampfer MJ, Manson JE, Rosner B, Hankinson SE, Colditz GA, Hennekens CH, Willet WC. 1997. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. Br Med J. 315(7105):396–400. doi:10.1136/bmj.315.7105.396
  • Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, Tenkanen L, Manninen V, Hovi T, MäNttäRi M, 2000. Infections, inflammation, and the risk of coronary heart disease. Circulation. 101(3):252–257. doi:10.1161/01.CIR.101.3.252
  • Schulte PA, Pandalai S, Wulsin V, Chun H. 2012. Interaction of occupational and personal risk factors in workforce health and safety. Am J Public Health. 102(3):434–448. doi:10.2105/AJPH.2011.300249
  • Solomon KR, Wilks M, Bachman A, Boobis A, Moretto A, Pastoor TP, Phillips R, Embry M. 2016. Problem formulation for risk assessment of combined exposures to chemicals and other stressors in humans. Crit Rev Toxicol. 46(10):835–844. doi:10.1080/10408444.2016.1211617
  • Steinberger J, Daniels SR. 2003. Obesity, insulin resistance, diabetes, and cardiovascular risk in children an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation. 107(10):1448–1453.
  • Steptoe A, Kivimaki M. 2012. Stress and cardiovascular disease. Nat Rev Cardiol. 9(6):360–370. doi:10.1038/nrcardio.2012.45
  • Stewart S, Sliwa K. 2009. Preventing CVD in resource-poor areas: perspectives from the 'real-world. Nat Rev Cardiol. 6(7):489–492. doi:10.1038/nrcardio.2009.79
  • Suter GW. 1999. Developing conceptual models for complex ecological risk assessments. Hum Ecol Risk Assess. 5(2):375–396.
  • Taylor WC, Poston WSC, Jones L, Kraft MK. 2006. Environmental justice: obesity, physical activity, and healthy eating. J Phys Act Health. 3(s1):S30–S54. doi:10.1123/jpah.3.s1.s30
  • Tran N, Barraj L. 2010. Contribution of specific dietary factors to CHD in US females. Public Health Nutr. 13(2):154–162. doi:10.1017/S1368980009990693
  • Tran N, Barraj L, Stettler N. 2012. Expert consultation.
  • U.S. EPA. 2003. Framework for Cumulative Risk Assessment. U.S. Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessment (CPHEA), formerly known as the National Center for Environmental Assessment (NCEA), Washington Office, Washington, DC, EPA/600/P-02/001F, 2003; https://www.epa.gov/risk/framework-cumulative-risk-assessment.
  • U.S. EPA. 2012. Cumulative Risk Assessment workgroup. Expert consultation.
  • Virtanen JK, Rissanen TH, Voutilainen S, Tuomainen TP. 2007. Mercury as a risk factor for cardiovascular diseases. J Nutr Biochem. 18(2):75–85. doi:10.1016/j.jnutbio.2006.05.001
  • Wang CH, Hsiao CK, Chen CL, Hsu LI, Chiou HY, Chen SY, Hsueh YM, Wu MM, Chen CJ. 2007. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol. 222(3):315–326. doi:10.1016/j.taap.2006.12.022
  • Williams IL, Wheatcroft SB, Shah AM, Kearney MT. 2002. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes. 26(6):754–764. doi:10.1038/sj.ijo.0801995
  • World Heart Federation. 2020. Champion Advocates Programme. The costs of CVD. http://www.championadvocates.org/en/champion-advocates-programme/the-costs-of-cvd.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.